Elizabeth Masson-Hurlburt
Patrimonio netto: 2 M $ in data 30/06/2026
Patrimonio netto: 2 M $ in data 30/06/2026
Elizabeth Masson-Hurlburt is currently Chief Operating & Commercial Officer at CorMedix, Inc., a position starting in 2026.
Formerly, Ms. Masson-Hurlburt was Vice President-Clinical Operations at Gemphire Therapeutics, Inc. from 2016 to 2018.
Education includes an undergraduate degree from Bay Path College and a graduate degree from Western Governors University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CORMEDIX INC. 0,36% | 04/02/2026 | 278.539 ( 0,36% ) | 2 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CORMEDIX INC. | Direttore operativo | - |
| Società | Posizione | Fine |
|---|---|---|
| METAVIA INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
CorMedix, Inc.
CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Bay Path College
Bay Path College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Governors University
Western Governors University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemphire Therapeutics, Inc.
Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale